Completed
This public workshop explored challenges and opportunities in manufacturing regenerative medicine therapeutics as the field evolves to accommodate higher volume production and increased capacity for delivering regenerative medicine treatments to patients. Presentations and discussions considered how new developments in areas such as closed systems, decentralized manufacturing, and automation can affect manufacturing cell- or gene-based therapies.
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.
Discover
Events
Convening Activities
Engage
Work with us